Telo Genomics announced that its proprietary blood-based TELO-MRD assay detected residual multiple myeloma cells in 92.9% of matched samples, outperforming the standard bone marrow EuroFlow next-generation flow cytometry which detected 54.8%. The TELO-MRD test not only counts residual cancer cells but also profiles their genomic instability, potentially offering better relapse risk assessment. The company plans to further develop and commercialize this non-invasive test by the end of 2027, aiming to improve personalized treatment for multiple myeloma patients.
Telo Genomics clinical research results provide context for readers. For those following the health sector, 35 of 91 US health stocks rose and 48 fell on Pluang. ENVB was priced at USD 1.46 with a -2.67% change, INO at USD 1.21 with +2.54%, and ABCL at USD 11.00 with -1.52%, as of Sep 15, 2026 16:41 WIB.
ZenaTech introduced Stacklens™, AI-powered smart safety glasses designed for field technicians and industrial workers, integrating hands-free AI assistance, real-time video support, and thermal imaging. The glasses aim to improve efficiency by allowi...
Polkadot (DOT) experienced a notable price surge on October 10, 2026, driven by broad market factors rather than any confirmed project-specific news. The rally appears linked to increased risk appetite, short-covering, and technical breakouts common ...
Last week saw two biotech companies successfully price their IPOs, alongside a billion-dollar data center developer, an emerging markets fintech, and a dental treatment company. Despite market caution limiting some IPO activity, biotechs remain activ...
The XRP Ledger patched a critical vulnerability in its payment engine that could have allowed attackers to create and spend XRP beyond the network's 100 billion token supply. The flaw, present in versions 3.4.0 and earlier, was fixed in version 3.4.1...
A decade-old bug in the XRP Ledger's payment system could have allowed attackers to create and spend new XRP tokens without funding them, violating the fixed supply of 100 billion XRP. The vulnerability involved a counting error in the ledger's built...
